Arcus Biosciences is a high-risk speculation with major upcoming catalysts, despite stock declines and Gilead's exit from the ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

Arcutis Biotherapeutics (NASDAQ:ARQT) shares rose on Wednesday after Padagis and its units requested a pause in an ongoing ...

Timken downgraded at Jefferies, saying potential for lower volumes and margin compression due to weakening short-cycle ...

BrainsWay's Q4 performance was strong, but a rising share count and flat margins have kept the stock from moving higher.

Hermès was one of the few luxury stocks rated Buy last November due to its robust fundamentals and favourable market ...

Just because a stock is a dependable dividend payer does not mean it makes a good investment. Check out 3 popular dividend ...

Sundry Photography/iStock Editorial via Getty Images BlackBerry (NYSE:BB) shares fell for seven straight sessions, as the ...

GE Vernova started at Positive at Susquehanna, saying it should benefit from global growth in power demand driven by data ...

Jefferies sees TJX Companies well-positioned in off-price retail, leveraging surplus inventory for growth, margin ...

Vaccine stocks have been under significant pressure since the FDA's top vaccine official resigned. Seeking Alpha analysts ...

Shiseido's declining profits and underperformance in core markets signal challenges.